Cefdinir Powder, For Suspension
Product Images NDC 76420-327

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 76420-327). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefdinir (Aa8c2254 7124 437a B691 010c18c8c80e 01)

Chemical structure diagram of cefdinir showing its molecular composition and connectivity as a cephalosporin antibiotic.*

FDA Label Image

Label (Labe 125mg 5ml)

Labels for Cefdinir for Oral Suspension USP 125 mg/5 mL powder for suspension by Asclemed USA, Inc. Two label formats shown with NDCs 76420-327-60 (60 quantity) and 76420-327-01 (100 quantity). Labels include manufacturer Lupin Pharmaceuticals, Inc., drug status RX, storage instructions, and caution statements. Relabeled by Enovachem Pharmaceuticals with address and QR code present.*

FDA Label Image

Label (Label 250mg 5ml)

Two pharmaceutical carton labels for Cefdinir Oral Suspension USP 250 mg/5 mL powder by Enovachem Pharmaceuticals, relabeled for Asclemed USA, Inc. Each label indicates the NDC numbers 76420-328-60 and 76420-328-01, with quantities of 60 and 100 respectively. The labels include manufacturer, storage instructions, and legal cautions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.